Skip to content

A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China

A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China (Based on Hospital)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02493569
Enrollment
3000
Registered
2015-07-09
Start date
2016-10-31
Completion date
Unknown
Last updated
2016-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast cancer, hospital, epidemiology, diagnosis, treatment

Brief summary

The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.

Detailed description

The study is a multicentric, retrospective clinical study based on the hospital. The target number of cases are X patients who are eligible for breast cancer after radical mastectomy. To collect the clinicopathological data and treatment data of the breast cancer patients and do the follow-up visit of all the patients who are included in the study.

Interventions

PROCEDUREThe radical mastectomy of breast cancer

The radical mastectomy of breast cancer could be used for the treatment of breast cancer during the observation.

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Female patients; * The hospitalized patients who are confirmed of the primary breast cancer histologically; * The date of the inpatients are within the month we chosen; * Patients who are within the month we chosen have been received or under receiving the relevant treatment including surgical treatment, chemotherapy and radiotherapy.

Exclusion criteria

* Male breast cancer patients; * Patients with breast cancer who are not under the chosen time; * Non hospitalized patients.

Design outcomes

Primary

MeasureTime frame
Overall five-year survival for the female breast cancer patients5 years

Contacts

Primary ContactYu Ren, MD,PhD
renyyyyy@126.com13700222161

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026